FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission
Published inHematological oncology, vol. 35, no. 3, p. 392-394
Publication date2017
Affiliation entities
Citation (ISO format)
BEAUVERD, Yan et al. FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission. In: Hematological oncology, 2017, vol. 35, n° 3, p. 392–394. doi: 10.1002/hon.2272
Main files (1)
Article (Published version)
Identifiers
- PID : unige:84044
- DOI : 10.1002/hon.2272
- PMID : 26563907
Journal ISSN0278-0232